(Q34621912)

3 August 2017

1 reference

title

Indecision about corticosteroids for bacterial keratitis: an evidence-based update (English)

1 reference

3 August 2017

Kirk R Wilhelmus

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

109

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

835-42; quiz 843

1 reference

Ambulatory visits for eye care by Medicare beneficiaries

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Use of eye care services among the 1991 Medicare population

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Incidence of ulcerative keratitis in a defined population from 1950 through 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Incidence of corneal ulceration in Madurai district, South India

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Empirical or culture-guided therapy for microbial keratitis? A plea for data

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

1 reference

7 January 2021

Drug interaction in the eye. Concurrent corticosteroid-antibiotic therapy for inflammatory keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

The Solubility of Antibiotic and Corticosteroid Combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Compatibility of corticosteroids and antibiotics in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Clinical trial design in studies of corticosteroids for bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Steroid controversy in sepsis and septic shock: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Topical steroids in the treatment of central and paracentral corneal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

The effect of cortisone on experimental pseudomonas corneal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Topical anti-inflammatory agents in an animal model of microbial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Ulcerative keratitis in bullous keratopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Epidemiology of microbial keratitis in southern California. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Predictive factors for response to medical therapy in bacterial ulcerative keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Risk factors in microbial keratitis leading to penetrating keratoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Studies on cortisone in ophthalmology

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Combined gentamicin-tobramycin-corticosteroid treatment. II. Effect on gentamicin-resistant Pseudomonas keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

The influence of cortisone in treatment of pseudomonas aeruginosa keratitis in rabbit eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Equine infectious keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

The clinical value of cortisone and ACTH in ocular disease; a preliminary assessment for the Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Infections of the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Combined use of antibiotics and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corticosteroid therapy in central stromal keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corticosteroids: An Unresolved Debate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Ocular inflammation, viruses, and the two-edged sword of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Antiinflammatory medications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corneal superinfection in acute hemorrhagic conjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Corneal Infection in Mucosal Scarring Disorders and SjöUgren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Endophthalmitis associated with microbial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

RECURRENCE OF A CORNEAL PSEUDOMONAS INFECTION AFTER TOPICAL STEROID THERAPY: REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Use of Corticosteroids in Combination with Antimicrobial Drugs in the Treatment of Infectious Corneal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

Pharmacokinetic considerations in the treatment of bacterial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2900963-6

7 January 2021

10.1016/S0161-6420(02)00963-6

Identifiers

DOI

1 reference

3 August 2017

1 reference